ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AMGN Stock Price » AMGN Stock News

Amgen Inc. Share News

 Amgen Inc. (mm) Stock Price
AMGN Stock Price
 Amgen Inc. (mm) Stock Chart
AMGN Stock Chart
 Amgen Inc. (mm) Stock News
AMGN Stock News
 Amgen Inc. (mm) Company Information
AMGN Company Information
 Amgen Inc. (mm) Stock Trades
AMGN Stock Trades

Bayer To Develop Cancer Treatment With Amgen

FRANKFURT -(Dow Jones)- German chemical and pharmaceutical company Bayer AG (BAYN.XE) said Tuesday it has agreed with Amgen Inc. (AMGN) to develop and commercialize a new antibody for treating cancer. MAIN FACTS: -Financial details of the deal weren't disclosed. -Bayer will collaborate with Amgen at its Munich site from the research phase to the completion of initial clinical trials. -After the initial trials have been completed, Bayer will be responsible for further development and commercialization of the product candidate. -In 2009, Bayer had entered into an agreement with Micromet, Inc. to produce another antibody. -Micromet was acquired by Amgen in early 2012. -Frankfurt Bureau, Dow Jones Newswires; 49-69-29725-500

Stock News for Amgen Inc. (AMGN)
12/01/201509:18:03CVS Health Plays Favorites with New Cholesterol Drugs
11/28/201515:41:02What Healthcare Dividend Stock Is Best?
11/28/201507:40:37Amgen Inc. Takes Aim at AbbVie Inc.
11/25/201516:00:00Amgen's First Biosimilar Biologics License Application For ABP...
11/25/201509:04:03Johnson & Johnson's Latest FDA Approval Could Spell Problems...
11/24/201508:38:03Healthcare's Greatest Dividend Stocks
11/24/201502:00:00European Commission Approves Amgen's BLINCYTO® (blinatumomab...
11/23/201508:50:00CVS Chooses New Cholesterol Drug for Caremark
11/23/201508:29:00CVS Chooses Repatha as New Cholesterol Drug for Caremark
11/23/201508:10:00Amgen Announces Repatha® Preferred Position On CVS Health Commercial...
11/21/201508:00:155 Things Amgen, Inc. Wants You to Know
11/20/201518:08:02The Best Healthcare ETF of the Week
11/20/201517:44:03Better Dividend Stock: Amgen or AstraZeneca PLC?
11/19/201516:00:00European Commission Approves Kyprolis® (carfilzomib) For Combination...
11/19/201510:03:08Amgen's Repatha Is Too Bloody Pricey for the U.K.
11/17/201509:42:033 Biotech Stocks You Don't Have to Babysit
11/17/201509:42:033 Biotech Stocks You Don't Have to Babysit
11/17/201509:42:033 Biotech Stocks You Don't Have to Babysit
11/17/201509:42:033 Biotech Stocks You Don't Have to Babysit
11/16/201516:00:00Amgen to Present IMLYGIC™ (Talimogene Laherparepvec) Data at t...

Amgen Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations